Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 49, 2019 - Issue 1
230
Views
5
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

In vitro analysis of itraconazole cis-diastereoisomers inhibition of nine cytochrome P450 enzymes: stereoselective inhibition of CYP3A

, &
Pages 36-42 | Received 24 Nov 2017, Accepted 05 Jan 2018, Published online: 22 Jan 2018

References

  • Chauret N, Gauthier A, Nicoll-Griffith DA. (1998). Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. Drug Metab Dispos 26:1–4
  • Copeland RA. 2000. Enzymes: a practical introduction to structure, mechanism, and data analysis. New York: Wiley-VCH, Inc
  • Florea NR, Capitano B, Nightingale CH, et al. (2003). Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients. Transplant Proc 35:2873–7
  • Haria M, Bryson HM, Goa KL. (1996). Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections. Drugs 51:585–620
  • Heykants J, van Peer A, van de Velde V, et al. (1989). The clinical pharmacokinetics of itraconazole: an overview. Mycoses 32(Suppl 1):67–87
  • Isoherranen N, Kunze KL, Allen KE, et al. (2004). Role of itraconazole metabolites in CYP3A4 inhibition. Drug Metab Dispos 32:1121–31
  • Krasulova K, Siller M, Holas O, et al. (2016). Enantiospecific effects of chiral drugs on cytochrome P450 inhibition in vitro. Xenobiotica 46:315–24
  • Kunze KL, Nelson WL, Kharasch ED, et al. (2006). Stereochemical aspects of itraconazole metabolism in vitro and in vivo. Drug Metab Dispos 34:583–90
  • Kurka O, Kucera L, Bednar P. (2016). Analytical and semipreparative chiral separation of cis-itraconazole on cellulose stationary phases by high-performance liquid chromatography. J Sep Sci 39:2736–45
  • Liu JO, Chong CR, Xu J, et al. (2012). Chirally pure isomers of itraconazole for use as angiogenesis inhibitors
  • Liu L, Bello A, Dresser MJ, et al. (2016). Best practices for the use of itraconazole as a replacement for ketoconazole in drug–drug interaction studies. J Clin Pharmacol 56:143–51
  • Lutz JD, Vandenbrink BM, Babu KN, et al. (2013). Stereoselective inhibition of CYP2C19 and CYP3A4 by fluoxetine and its metabolite: implications for risk assessment of multiple time-dependent inhibitor systems. Drug Metab Dispos 41:2056–65
  • Mahnke CB, Sutton RM, Venkataramanan R, et al. (2003). Tacrolimus dosage requirements after initiation of azole antifungal therapy in pediatric thoracic organ transplantation. Pediatr Transplant 7:474–8
  • Nett JE, Andes DR. (2016). Antifungal agents: spectrum of activity, pharmacology, and clinical indications. Infect Dis Clin N Am 30:51–83
  • Niwa T, Imagawa Y, Yamazaki H. (2014). Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450. Curr Drug Metab 15:651–79
  • Niwa T, Inoue-Yamamoto S, Shiraga T, Takagi A. (2005a). Effect of antifungal drugs on cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 activities in human liver microsomes. Biol Pharm Bull 28:1813–16
  • Niwa T, Shiraga T, Takagi A. (2005b). Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. Biol Pharm Bull 28:1805–8
  • Novotna A, Krasulova K, Bartonkova I, et al. (2014). Dual effects of ketoconazole cis-enantiomers on CYP3A4 in human hepatocytes and HepG2 Cells. PLoS One 9:e111286
  • Peng CC, Shi W, Lutz JD, et al. (2012). Stereospecific metabolism of itraconazole by CYP3A4: dioxolane ring scission of azole antifungals. Drug Metab Dispos 40:426–35
  • Phillips IR, Shephard EA. 2006. Cytochrome P450 protocols. Totowa (NJ): Humana Press
  • Shin JG, Kane K, Flockhart DA. (2001). Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol. Br J Clin Pharmacol 51:45–52
  • Smith SW. (2009). Chiral toxicology: it's the same thing…only different. Toxicol Sci 110:4–30
  • Stepankova M, Pastorkova B, Bachleda P, Dvorak Z. (2017). Itraconazole cis-diastereoisomers activate aryl hydrocarbon receptor AhR and pregnane X receptor PXR and induce CYP1A1 in human cell lines and human hepatocytes. Toxicology 383:40–9
  • Templeton IE, Thummel KE, Kharasch ED, et al. (2008). Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo. Clin Pharmacol Ther 83:77–85
  • Vanden Bossche H, Marichal P, Gorrens J, et al. (1989). Biochemical approaches to selective antifungal activity. Focus on azole antifungals. Mycoses 32(Suppl 1):35–52
  • Venkatakrishnan K, von Moltke LL, Greenblatt DJ. (2000). Effects of the antifungal agents on oxidative drug metabolism: clinical relevance. Clin Pharmacokinet 38:111–80

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.